Clinical Implications Beyond Diabetes and Obesity While retatrutide is being tested primarily for obesity and type 2 diabetes , its impact on LDL suggests future use in: Cardiovascular disease prevention (alongside statins or in statin-intolerant patients) Metabolic syndrome management Nonalcoholic fatty liver disease (NAFLD/NASH) , since LDL and triglyceride metabolism are central to liver health Complementary to Statins Unlike statins, which only reduce LDL synthesis, retatrutide may work through multiple lipid pathways , making it synergistic rather than redundant
Silenced food noise: Food noise refers to the persistent and unwavering focus on food that can plague a persons thoughts
1 The same applies to other commonly prescribed SSRIs, like citalopram, fluoxetine, and escitalopram, as well as SNRIs, like venlafaxine and duloxetine
Studies suggest that Mod GRF 1-29 might impact the synthesis and release of key regulatory molecules, which are critical in cellular regeneration and adaptation
Now, why would we have a naturally occurring peptide, a protein within our gut that's involved in wound healing and repair